RRD, OXGN, CRWE, DAVE - PennyGovernance.com Stock Highlights! R. R. Donnelley & Sons Company, OXiGENE, Crown Equity Holdings, Fa
RNET, CRWE, OXGN, NDAQ - CRWEPicks.com Stock Highlights! RigNet, Crown Equity Holdings, OXiGENE, The NASDAQ OMX Group
RVSN, OXGN, FCEL - CRWESelect.com Stock News! Radvision Ltd., OXiGENE, FuelCell Energy (Video Included Inside)
To view video, and read the full article visit URL http://crweselect.com/27742/stock-alerts/rvsn-oxgn-fcel-crweselectcom-st...
Radvision Ltd. (NASDAQ:RVSN)
(OXGN, KTOS, SWKS) PennyOmega.com Watch List for Friday Nov. 04, 2011
KTOS, Kratos Defense & Security Solutions, Inc.
** On its third quarter fiscal 2011, KTOS posted revenues of $211.0 million, a 75.97% increase compared to revenues of $119.9 million in the same period a year ago. For the fourth quarter, KTOS is forecasting revenues to increase to approximately $230 to $240 million.
FOLD, CLNO, SVNT, OXGN, - PennyToBuck.com Stock Highlights!
Amicus Therapeutics, Inc. (Nasdaq:FOLD) and GlaxoSmithKline (GSK) announced that the first patient has commenced dosing in a Phase 3 global registration study (Study 012) to compare the safety and efficacy of Amigal(TM) (migalastat HCl) and enzyme replacement therapy (ERT) for the treatment of Fabry disease.
OXGND, CRWE, VLNC, ORFG, SAPX - Market Update From DrStockPick.com!
KONE, CRWE.OB, AVOT.PK, OXGN, OXGN, - CRWESelect.com Stock Report! Kingtone Wirelessinfo Solution Holding Ltd
Kingtone Wirelessinfo Solution Holding Ltd. (NASDAQ:KONE) a leading China-based software and solutions developer focused on wirelessly enabling businesses and government agencies to more efficiently manage their operations, announced financial results for the fourth quarter and fiscal year 2010.
GERN, ONNN, OXGN, DIS, - Geron, ON Semiconductor, Oxigene and Walt Disney Stock Report! From CRWESelect.com
Geron Corporation (NASDAQ:GERN) previously announced the publication of preclinical data demonstrating that the company’s telomerase inhibitor drug, imetelstat (GRN163L), currently in Phase 2 clinical trials, targets cancer stem cells from multiple myeloma, pancreatic and breast cancers.